| Drug Type Small molecule drug | 
| Synonyms OST 246, OST-246 | 
| Target | 
| Action inhibitors | 
| Mechanism JAK3 inhibitors(Tyrosine-protein kinase JAK3 inhibitors), MAP3K11 inhibitors(Mitogen-activated protein kinase kinase kinase 11 inhibitors), TYK2 inhibitors(Tyrosine-protein kinase 2 inhibitors) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePreclinical | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Autoimmune Diseases | Preclinical | Spain  | - | |
| Inflammation | Preclinical | Spain  | - | 





